Agenda

 

Approx. 50 minutes

Personalizing the Management of Advanced Gastric Cancer

Presented on March 2nd, 2015

Kelsey Klute, MD

Weill Cornell Medical College

Manish A. Shah, MD

Weill Cornell Medical College

 

Approx. 50 minutes

Preventing and Treating Inhibitors in Patients with Hemophilia: Strategies for Success

Presenting on March 6th, 2015

Lindsey A. Greene, MD

The Children's Hospital of Philadelphia

Patrick F. Fogarty, MD

Perelman School of Medicine, University of Pennsylvania

 

Approx. 50 minutes

New Directions in the Management of Mantle Cell Lymphoma

Presented on February 17th, 2015

James O. Armitage, MD

University of Nebraska Medical Center

Julie M. Vose, MD, MBA

University of Nebraska Medical Center

 

Approx. 50 minutes

Managing Diffuse Large B-cell Lymphoma (DLBCL): A Case-based Approach to Treatment Selection

Presented on October 22nd, 2014

Andre Goy, MD, MS

John Theurer Cancer Center, at Hackensack University Medical Center

Andrew Zelenetz, MD, PhD

Professor of Medicine, Weill-Cornell Medical College

 

Approx. 50 minutes

Evaluating New & Emerging Treatment Options for Non-Hodgkin Lymphoma (NHL)

Presented on October 22nd, 2014

Andre Goy, MD, MS

John Theurer Cancer Center, at Hackensack University Medical Center

Andrew Zelenetz, MD, PhD

Professor of Medicine, Weill-Cornell Medical College

 

Approx. 50 minutes

Therapeutic Decision-making in Chronic Lymphocytic Leukemia (CLL)

Presented on October 22nd, 2014

Jennifer Brown, MD, PhD

Harvard Medical School

Nicole Lamanna, MD

Columbia University

 

Approx. 50 minutes

Emerging Therapies in CLL: Promise for Difficult-to-Treat Patients?

Presented on October 22nd, 2014

Jennifer Brown, MD, PhD

Harvard Medical School

Nicole Lamanna, MD

Columbia University

 

Approx. 50 minutes

Evidence-Based Management of Advanced and Metastatic Breast Cancer: A Close Look at New Innovations and Emerging Therapies

Presented on October 7th, 2014

Erica L. Mayer, MD, MPH

Harvard Medical School

Harold J. Burstein, MD, PhD

Harvard Medical School

 

Approx. 50 minutes

Invasive Mold Infection: Understanding the Impact - A Focus on Aspergillosis and Mucromycosis

Featuring Dr. David R. Andes, Dr. Debra A. Goff and Dr. Amar Safdar

*This session is not eligible for AMA PRA Category 1 Credits TM

Sponsored by Astellas Pharma US, Inc.
Presented on January 6th, 2015

Amar Safdar, MD

New York University Langone Medical Center

David R. Andes, MD

University of Wisconsin - Madison

Debra A. Goff, PharmD, FCCP

The Ohio State University

 

Approx. 50 minutes

Managing Ph+ Chronic Myelogenous Leukemia (CML) Resistant or Intolerant to Prior Therapy

Featuring Dr. George Howard

*This session is not eligible for AMA PRA Category 1 Credits TM

Sponsored by Pfizer, Inc.
Presented on September 19th, 2014

George Howard, MD

Oakland University William Beaumont School of Medicine

 

Approx. 50 minutes

A Patient-Focused Approach to the Evolving Treatment of Hemophilia

Featuring Dr. Michael D. Tarantino

*This session is not eligible for AMA PRA Category 1 Credits TM

Sponsored by Pfizer, Inc.
Presented October 2nd, 2014

Michael D. Tarantino, MD

University of Illinois College of Medicine Peoria, IL

 

Approx. 50 minutes

Shedding Light on a Second-Line Advanced RCC Treatment

Featuring Dr. Robert Alter

*This session is not eligible for AMA PRA Category 1 Credits TM

Sponsored by Pfizer, Inc.
Presented on June 25th, 2014

Robert S. Alter, MD

John Theurer Cancer Center

 

Approx. 50 minutes

An Effective Option for First-Line Treatment of Patients With Advanced RCC

Featuring Dr. Thomas Hutson

*This session is not eligible for AMA PRA Category 1 Credits TM

Sponsored by Pfizer, Inc.
Presented on June 25th, 2014

Thomas Hutson, DO, PharmD, FACP

Texas Oncology-Baylor Charles A. Sammons Cancer Center

 

Approx. 50 minutes

A Treatment Option for Advanced RCC With Pivotal Data in Patients With Poor Prognosis

Featuring Dr. Ulka Vaishampayan

*This session is not eligible for AMA PRA Category 1 Credits TM

Sponsored by Pfizer, Inc.
Presented on June 25th, 2014

Ulka Vaishampayan, MD

Wayne State University

 

Approx. 50 minutes

Clinical Strategies for Appropriate Molecular Testing and Diagnosis in NSCLC: Model Multidisciplinary Lung Tumor Board

Featuring Dr. Alexander C. Mackinnon, Dr. Septimiu Murgu, and Dr. Ravi Salgia

*This session is not eligible for AMA PRA Category 1 Credits TM

Sponsored by Pfizer, Inc.
Presented on June 18th, 2014

Alexander C. Mackinnon, Jr., MD, PhD

Medical College of Wisconsin

Ravi Salgia, MD, PhD

University of Chicago Medicine

Septimiu Murgu, MD

University of Chicago Medicine

 

Approx. 50 minutes

Clinical Decision Making in Treating Patients With mCRPC Who Have Progressed on ADT

Featuring Dr. Judd W Moul

*This session is not eligible for AMA PRA Category 1 Credits TM

Sponsored by Janssen Biotech, Inc.
Presented on December 17th, 2014

 
OmedLive
Watch Connect online with thousands of your peers.
Connect Engage in real-time Q&A with top factuly.
Choose Learn about the latest treatment options.
Connect Earn AMA PRA
Category 1 Credits
™.